History about the discovery of the renin-angiotensin system
- PMID: 11751697
- DOI: 10.1161/hy1201.101214
History about the discovery of the renin-angiotensin system
Abstract
The history of the discovery of the renin-angiotensin system began in 1898 with the studies made by Tigerstedt and Bergman, who reported the pressor effect of renal extracts; they named the renal substance renin based on its origin. In 1934, Harry Goldblatt induced experimental hypertension in dogs by clamping a renal artery. About 1936, simultaneously in the Medical School of the University of Buenos Aires, Argentina, and in the Eli-Lilly Laboratories in Indianapolis, 2 independent groups of researchers, using the Goldblatt technique to produce experimental hypertension, demonstrated renal secretion of a pressor agent similar to renin. In the following years, both teams described the presence of a new compound in the renal vein blood of ischemic kidneys. This agent was extracted from blood with 70% acetone and had a short pressor effect. The final conclusion was that renin acted enzymatically on a plasma protein to produce the new substance. In Buenos Aires, it was called hypertensin; in the United States, angiotonin. In 1958, Eduardo Braun Menéndez from Argentina and Irving H. Page from the United States agreed to name it angiotensin.
Similar articles
-
A cornerstone in the history of hypertension: the seventieth anniversary of the discovery of angiotensin.J Cardiovasc Med (Hagerstown). 2010 Apr;11(4):260-4. doi: 10.2459/JCM.0b013e3283356607. J Cardiovasc Med (Hagerstown). 2010. PMID: 19956076
-
[History of the renin-angiotensin system: great men, a great finding].Rev Med Chil. 2014 Sep;142(9):1210-6. doi: 10.4067/S0034-98872014000900017. Rev Med Chil. 2014. PMID: 25517063 Spanish.
-
The Birth of Angiotensin: An International Compromise.Am J Med Sci. 2019 Mar;357(3):179-183. doi: 10.1016/j.amjms.2018.08.017. Epub 2018 Sep 4. Am J Med Sci. 2019. PMID: 30798942
-
Seven decades of angiotensin (1939-2009).Peptides. 2009 Oct;30(10):1945-50. doi: 10.1016/j.peptides.2009.07.003. Epub 2009 Jul 10. Peptides. 2009. PMID: 19595728 Review.
-
A memorial to Robert Tiegerstedt: the centennial of renin discovery.Hypertension. 1998 Dec;32(6):953-7. doi: 10.1161/01.hyp.32.6.953. Hypertension. 1998. PMID: 9856956 Review. No abstract available.
Cited by
-
Proposal for the use of angiotensin II in distributive shock after extracorporeal circulation - position paper of the Section of Intensive Care Medicine and the Section of Cardiothoracic Anaesthesiology of the Polish Society of Anaesthesiology and Intensive Therapy.Kardiochir Torakochirurgia Pol. 2024 Jun;21(2):96-98. doi: 10.5114/kitp.2024.141146. Epub 2024 Jun 30. Kardiochir Torakochirurgia Pol. 2024. PMID: 39055252 Free PMC article. Review.
-
Systematic-Narrative Hybrid Literature Review: Crosstalk between Gastrointestinal Renin-Angiotensin and Dopaminergic Systems in the Regulation of Intestinal Permeability by Tight Junctions.Int J Mol Sci. 2024 May 20;25(10):5566. doi: 10.3390/ijms25105566. Int J Mol Sci. 2024. PMID: 38791603 Free PMC article. Review.
-
Obesity-induced skeletal muscle remodeling: A comparative analysis of exercise training and ACE-inhibitory drug in male mice.Physiol Rep. 2024 May;12(9):e16025. doi: 10.14814/phy2.16025. Physiol Rep. 2024. PMID: 38684378 Free PMC article.
-
Exploring FDA-Approved Frontiers: Insights into Natural and Engineered Peptide Analogues in the GLP-1, GIP, GHRH, CCK, ACTH, and α-MSH Realms.Biomolecules. 2024 Feb 22;14(3):264. doi: 10.3390/biom14030264. Biomolecules. 2024. PMID: 38540684 Free PMC article. Review.
-
The ACE inhibitor captopril inhibits ACN-1 to control dauer formation and aging.Development. 2024 Feb 1;151(3):dev202146. doi: 10.1242/dev.202146. Epub 2024 Feb 12. Development. 2024. PMID: 38284547
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
